Sight Sciences announces European launch of OMNI Surgical System Ergo-Series

Sight Sciences announced the CE Mark at the ESCRS Winter Meeting in Frankfurt. Image credit: ©Anselm – stock.adobe.com

Sight Sciences, Inc. announced it will launch the Ergo-Series of the OMNI Surgical System in Europe. The surgical technology received a CE Mark under the EU Medical Device Regulation, Sight Sciences announced in a press release.¹ The news was announced at the European Society of Cataract and Refractive Surgeons (ESCRS) Winter Meeting in Frankfurt, Germany.

The Ergo-Series, which launched last March in the United States, enhances ophthalmic surgeons’ ability to perform minimally invasive, implant-free glaucoma procedures. It is suitable for use in procedures for adults with open-angle glaucoma. The technology boasts enhanced ergonomics, including a cannula tip optimised for precision and comfortable use. The OMNI Surgical System is CE Marked for catheterisation and transluminal viscodilation of Schlemm’s canal and the cutting of trabecular meshwork to reduce intraocular pressure.

Professor Fritz Hengerer, Chief Medical Officer and director at Bürgerhospital Eye Clinic in Frankfurt, said in a news release he was impressed by the improved ergonomics and design features of the OMNI Ergo-Series. “These upgrades make the OMNI Surgical System even more user-friendly which could encourage surgeons to intervene earlier, when appropriate, to help delay disease progression, thus helping to preserve vision and potentially reduce the medication burden of patients with glaucoma,” Prof Hengerer stated.

“The previous iteration of the OMNI Surgical System was seamlessly incorporated into my practice,” added Dr Andrew Tatham, consultant ophthalmic surgeon at Princess Alexandra Eye Pavilion in Edinburgh, Scotland, and NHS Research Scotland Clinical Lead for Ophthalmology. “The enhanced cannula tip can provide gentle, precise access to Schlemm’s canal and improved tactile feedback, giving the surgeon confidence at every step of the procedure.”

Paul Badawi, co-founder and CEO of California, US-based Sight Sciences, said the OMNI Ergo-Series has received positive feedback from surgeons throughout the United States. According to the press release, practitioners reported the improved handle ergonomics and simplified viscoelastic preparation were particularly appealing features.¹ “I believe these improvements make OMNI even more accessible for surgeons treating all stages of open-angle glaucoma,” Dr Tatham commented.

Reference

1. Sight Sciences Announces European Launch of the Ergo-Series of the OMNI® Surgical System at the ESCRS Winter Meeting. News release. Sight Sciences, Inc. Published February 14, 2024. Accessed February 15, 2024.